Nisenbaum, L.K.; Downing, A.M.; Zhao, F.; Millen, B.A.; Munsie, L.; Kinon, B.J.; Adams, D.H.; Gomez, J.C.; Penny, M.A.
Serotonin 2A Receptor SNP rs7330461 Association with Treatment Response to Pomaglumetad Methionil in Patients with Schizophrenia. J. Pers. Med. 2016, 6, 9.
https://doi.org/10.3390/jpm6010009
AMA Style
Nisenbaum LK, Downing AM, Zhao F, Millen BA, Munsie L, Kinon BJ, Adams DH, Gomez JC, Penny MA.
Serotonin 2A Receptor SNP rs7330461 Association with Treatment Response to Pomaglumetad Methionil in Patients with Schizophrenia. Journal of Personalized Medicine. 2016; 6(1):9.
https://doi.org/10.3390/jpm6010009
Chicago/Turabian Style
Nisenbaum, Laura K., AnnCatherine M. Downing, Fangyi Zhao, Brian A. Millen, Leanne Munsie, Bruce J. Kinon, David H. Adams, Juan Carlos Gomez, and Michelle Ann Penny.
2016. "Serotonin 2A Receptor SNP rs7330461 Association with Treatment Response to Pomaglumetad Methionil in Patients with Schizophrenia" Journal of Personalized Medicine 6, no. 1: 9.
https://doi.org/10.3390/jpm6010009
APA Style
Nisenbaum, L. K., Downing, A. M., Zhao, F., Millen, B. A., Munsie, L., Kinon, B. J., Adams, D. H., Gomez, J. C., & Penny, M. A.
(2016). Serotonin 2A Receptor SNP rs7330461 Association with Treatment Response to Pomaglumetad Methionil in Patients with Schizophrenia. Journal of Personalized Medicine, 6(1), 9.
https://doi.org/10.3390/jpm6010009